国际医药卫生导报2011，Vol.17Issue(12)：1505-1508,4.DOI:10.3760/cma.j.issn.1007-1245.2011.12.036
2008-2010年我院抗骨质疏松药物用药分析
Application analysis of anti-osteoporosis from 2008 to 2010 in a hospital
摘要
Abstract
Objective To investigate the use and its tendency of anti-osteoporosis in our hospital.Methods The anti-osteoporosis used in Guangzhou Red Cross Hospital from January 2008 to December 2010 was analyzed in respect to consumption sum,defined daily dose(DDDs)and daily drug cost (DDC),etc.Results The annual consumption sum of anti-osteoporosis showed a upward trend in our hospital during 2008-2010,the growth rate is 43.88%in 2009 and 31.51%in 2010.The Chinese patent medicine is the highest in consumption sum,the ratios are 44.61%,38.81%and 34.58%respectively;the consumption of selective estrogen receptor modulators increased rapidly,the growth rate is 237.59%in 2009 and 48.3%in 2010;the calcium preparations topped the list of anti-osteoporosis in terms of DDDs.it ranked second in DDDs in 2008 and the first in 2009 and 2010.Conclusion The application of anti-osteoporosis drugs can promote the rational use and clinical monitoring with great significance.关键词
抗骨质疏松药/金额排序/用药频度/用药分析Key words
Anti-osteoporosis/Amount sort/Defined daily dose/Analysis引用本文复制引用
叶凤英..2008-2010年我院抗骨质疏松药物用药分析[J].国际医药卫生导报,2011,17(12):1505-1508,4.
